Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Boston Scientific Corporation: OptiCross Coronary Imaging Catheters Recalled for Decreased Image Brightness

Agency Publication Date: March 28, 2024
Share:
Sign in to monitor this recall

Summary

Boston Scientific Corporation is recalling 239 units of OptiCross Coronary Imaging Catheters (Model REF H749518080120) because they were manufactured using an incorrect voltage setting. This manufacturing defect can lead to decreased image brightness during medical procedures, which may interfere with a physician's ability to clearly see the coronary arteries. These specific catheters were distributed internationally to Japan and were manufactured in the United States. Because these are specialized medical devices, you should contact your healthcare provider or the manufacturer regarding the next steps for any affected units.

Risk

The incorrect voltage setting during manufacturing causes a reduction in image brightness, which can prevent doctors from obtaining clear diagnostic images during heart catheterization procedures. This lack of visibility could lead to procedural delays or difficulties in accurately assessing a patient's condition.

What You Should Do

  1. Identify if you have the OptiCross Coronary Imaging Catheter (REF H749518080120) by checking the device packaging for UDI/DI 08714729938415.
  2. Check the product label for the following specific affected lot numbers: 32426901, 32429407, or 32625286.
  3. If you identify a device from an affected lot, contact your healthcare provider or Boston Scientific Corporation to discuss the recall and obtain further instructions.
  4. Contact the FDA hotline at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls for additional information regarding this medical device recall.

Your Remedy Options

๐Ÿ“‹Other Action

Contact healthcare provider or manufacturer

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: OptiCross Coronary Imaging Catheter, REF H749518080120
Model / REF:
REF H749518080120
UPC Codes:
08714729938415
Lot Numbers:
32426901
32429407
32625286

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94162
Status: Active
Manufacturer: Boston Scientific Corporation
Sold By: hospitals; medical distributors
Manufactured In: United States
Units Affected: 239 units
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.